BioSig to Present at NobleCon18 Capital Markets Conference
Westport, CT, April 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology...
Day: April 7, 2022
SmileDirectClub to Report First Quarter 2022 Results on May 9, 2022
NASHVILLE, Tenn., April 07, 2022 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the...
Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022
SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein...
Bolt Biotherapeutics to Present at 21st Annual Needham Healthcare Conference
REDWOOD CITY, Calif., April 07, 2022 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biotechnology company pioneering a new...
38th Edition of the Funds from the Heart Fundraiser
Nearly 300 IGA supermarkets rally for heart healthMONTREAL and QUEBEC CITY, April 07, 2022 (GLOBE NEWSWIRE) -- In collaboration with...
Impel NeuroPharma To Present At The 21st Annual Needham Healthcare Conference
SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) -- Impel NeuroPharma (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people...
Webinar: Piezo Motion’s Miniature Motors Are Driving Next Generation of Medical Devices
On April 21, Dr. Mark Broderick will discuss how Piezo Motion is revolutionizing the miniature-motor industry and providing viable solutions...
Rubius Therapeutics to Host Investor Webcast to Discuss Updated Clinical Data at AACR from the Ongoing Monotherapy Phase 1 Arm of the Phase 1/2 Clinical Trial of RTX-240 in Patients with Advanced Solid Tumors on April 8, 2022, at 1:15 PM ET
CAMBRIDGE, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is biologically...
LifeMD to Participate in the 21st Annual Needham Virtual Healthcare Conference
NEW YORK, April 07, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that...
Neoleukin Therapeutics to Present at Canaccord Genuity Horizons in Oncology Conference
SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to...
Propella Therapeutics Announces Licensing Agreement with Jiangsu Aosaikang Pharmaceutical Co. Ltd. (ASK Pharm) for Development and Commercial Rights to CGS-200-5 in Greater China
Propella to Receive Upfront Payment, Regulatory and Sales Milestones, and Royalties Phase 2 Study of CGS-200-5 Reduced Pain by 50%...
VYNE Therapeutics Announces Positive Phase 1b Efficacy Data for FMX114 from Phase 1b/2a Trial for the Treatment of Mild-to-Moderate Atopic Dermatitis
At week 2, FMX114 demonstrated a statistically significant reduction in both absolute and percent change in ADSI score compared to...
Lexicon Pharmaceuticals to Participate in the 21st Annual Needham Virtual Healthcare Conference
THE WOODLANDS, Texas, April 07, 2022 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Jeffrey L. Wade,...
LianBio Appoints Wei Wei Chen to Board of Directors
SHANGHAI and PRINCETON, N.J., April 07, 2022 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative...
Apexigen Announces That New Data From Phase 2 Trial Evaluating its CD40 Antibody Sotigalimab in Combination With Pembrolizumab in Patients With Metastatic Melanoma Will Be Presented at the AACR Annual Meeting 2022
Data to be featured in an oral presentation on April 12, 2022 at 3:35pm (CDT)SAN CARLOS, Calif., April 07, 2022...
Harpoon Therapeutics to Participate in Canaccord Genuity Horizons in Oncology Virtual Conference
SOUTH SAN FRANCISCO, Calif., April 07, 2022 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing...
Agile Therapeutics® Announces Poster Presentation at the 2022 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists (ACOG)
The abstract was accepted by ACOG and will be presented from May 4th – May 6th, 2022PRINCETON, N.J., April 07,...
Verrica Pharmaceuticals Announces Participation in the 21st Annual Needham Virtual Healthcare Conference
WEST CHESTER, Pa., April 07, 2022 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing...
VectivBio Reports Full Year 2021 Financial Results and Provides Business Update
Significant Progress Across Multiple Programs with Key Upcoming Catalysts Beginning H2 2022 STARS Phase 3 Program of Apraglutide in Short...
OraSure Technologies’ Subsidiary DNA Genotek Launches the First Device with De Novo Authorization from the FDA for the Preservation and Stabilization of Microbiome Samples
BETHLEHEM, Pa., April 07, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home...
